How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists
The severity of the COVID-19 pandemic has led to an unprecedented effort to develop vaccines against SARS-CoV-2 infection since this seems to be the most effective strategy to counter the pandemic. In the past weeks, the administration of vaccines has started in different parts of the world sustaini...
Main Authors: | Alfredo Papa, Franco Scaldaferri, Lorenzo Maria Vetrone, Matteo Neri, Antonio Gasbarrini, Loris Riccardo Lopetuso |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/3/248 |
Similar Items
-
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center
by: Marco Pizzoferrato, et al.
Published: (2019-09-01) -
IBD or strongyloidiasis?
by: Marta Maia Boscá-Watts, et al. -
Liquid biopsy for patients with IBD-associated neoplasia
by: Hideaki Kinugasa, et al.
Published: (2020-12-01) -
Remote Monitoring Empowerment of Patients with IBDs during the SARS-CoV-2 Pandemic
by: Mauro Mastronardi, et al.
Published: (2020-10-01) -
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
by: Loris Riccardo Lopetuso, et al.
Published: (2020-06-01)